KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Non-Current Assets (2016 - 2025)

Evolent Health (EVH) has 11 years of Non-Current Assets data on record, last reported at $1.9 billion in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 3.8% year-over-year to $1.9 billion; the TTM value through Sep 2025 reached $7.6 billion, down 3.01%, while the annual FY2024 figure was $1.9 billion, 2.97% down from the prior year.
  • Non-Current Assets reached $1.9 billion in Q3 2025 per EVH's latest filing, down from $1.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.1 billion in Q1 2023 and bottomed at -$505.6 million in Q2 2021.
  • Average Non-Current Assets over 5 years is $1.5 billion, with a median of $1.9 billion recorded in 2024.
  • Peak YoY movement for Non-Current Assets: surged 23105.44% in 2021, then dropped 6.58% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $895.5 million in 2021, then surged by 49.55% to $1.3 billion in 2022, then skyrocketed by 49.09% to $2.0 billion in 2023, then fell by 2.97% to $1.9 billion in 2024, then fell by 2.78% to $1.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $1.9 billion in Q3 2025, $1.9 billion in Q2 2025, and $1.9 billion in Q1 2025.